Médecine

Paramédical

Autres domaines


S'abonner

A single-institution assessment of superficial spreading melanoma (SSM) in the pediatric population: Molecular and histopathologic features compared with adult SSM - 27/12/17

Doi : 10.1016/j.jaad.2017.05.051 
Anna Elisa Verzì, MD a, Jeffrey A. Bubley, BA a, Alexandra M. Haugh, BA a, Bin Zhang, MS a, Annette Wagner, MD a, b, Lacey Kruse, MD a, b, Dennis P. West, PhD a, Jeffrey Wayne, MD c, Joan Guitart, MD a, Pedram Gerami, MD a, d,
a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 
c Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 
d Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois 
b Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois 

Correspondence to: Pedram Gerami, MD, Northwestern University, Department of Dermatology, 676 N St. Clair St, Suite 1765, Chicago, IL 60611.Northwestern UniversityDepartment of Dermatology676 N St. Clair St, Suite 1765ChicagoIL60611

Abstract

Background

The epidemiology of pediatric melanoma is distinct from that seen in adults. This is more distinguishable when pediatric patients are separated into prepubertal and adolescent groups.

Objective

In this study, we compared epidemiologic, clinical, histologic, and molecular characteristics of pediatric superficial spreading melanoma (SSM) in prepubertal and adolescent patients to that in adults.

Method

We reviewed our database for pediatric melanomas, comparing SSM data between pediatric and adult cases for pathologic stage at presentation, ratio of radial to vertical growth phase, average Breslow depth and mitotic index, and frequency of fluorescence in situ hybridization (FISH) positivity.

Results

Of 84 pediatric melanomas, 38 were SSM, and 5 of the latter (6%) were prepubertal. There were no significant differences when pediatric and adult SSM were compared for stage at presentation, ratio of radial to vertical growth phase, average Breslow depth and mitotic count, or frequency of FISH positivity. A significant difference was detected for SSM arising from a precursor nevus (80% of pediatric cases versus 30% of adult cases).

Limitations

Follow-up time was limited for both cohorts.

Conclusions

SSM melanoma is infrequent in childhood, particularly in the prepubertal years. Features such as tumor stage, Breslow depth, mitotic activity, and FISH positivity suggest morphologic and molecular characteristics similar to those of adult SSM.

Le texte complet de cet article est disponible en PDF.

Key words : adolescent, children, FISH, radial growth phase, superficial spreading melanoma, vertical growth phase

Abbreviations used : FISH, SSM


Plan


 Supported by the IDP Foundation.
 Dr Gerami has served as a consultant for Myriad Genomics, DermTech Int, and Castle Biosciences and has received honoraria for this service. Drs Verzì, Wagner, Kruse, West, Wayne, and Guitart; Mr Bubley; Ms Haugh; and Mr Zhang have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 Reprints not available from the authors.


© 2017  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 77 - N° 5

P. 886-892 - novembre 2017 Retour au numéro
Article précédent Article précédent
  • Outpatient dermatology consultation impacts the diagnosis and management of pediatric oncology patients: A retrospective study
  • Hannah Song, Sarah N. Robinson, Jennifer T. Huang
| Article suivant Article suivant
  • Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status
  • Hildur Helgadottir, Rainer Tuominen, Håkan Olsson, Johan Hansson, Veronica Höiom

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.